Research developments in metabolism 2018.

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Metabolism: Clinical and Experimental

• Publication date

  2019-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.metabol.2018.11.011PMID 30503805
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacotherapy of obesity: Available medications and drugs under investigation.

  2019cited by this paper
• Energy-matched moderate and high intensity exercise training improves nonalcoholic fatty liver disease risk independent of changes in body mass or abdominal adiposity - A randomized trial.

  2018cited by this paper
• BDNF mimetic alleviates body weight gain in obese mice by enhancing mitochondrial biogenesis in skeletal muscle.

  2018cited by this paper
• Non-targeted profiling of circulating microRNAs in women with polycystic ovary syndrome (PCOS): effects of obesity and sex hormones.

  2018cited by this paper
• Differential associations of lower cardiac vagal tone with insulin resistance and insulin secretion in recently diagnosed type 1 and type 2 diabetes.

  2018cited by this paper
• Blunted cerebral oxygenation during exercise in women with gestational diabetes mellitus: associations with macrovascular function and cardiovascular risk factors.

  2018cited by this paper
• Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis.

  2018cited by this paper
• The OEA effect on food intake is independent from the presence of PPARα in the intestine and the nodose ganglion, while the impact of OEA on energy expenditure requires the presence of PPARα in mice.

  2018cited by this paper
• The prebiotic inulin improves substrate metabolism and promotes short-chain fatty acid production in overweight to obese men.

  2018cited by this paper
• Physiology of Activins/Follistatins: Associations With Metabolic and Anthropometric Variables and Response to Exercise

  2018cited by this paper
• Liver-specific ablation of insulin-degrading enzyme causes hepatic insulin resistance and glucose intolerance, without affecting insulin clearance in mice.

  2018cited by this paper
• Involvement of acetyl-CoA-producing enzymes in the deterioration of the functional potential of adipose-derived multipotent cells from subjects with metabolic syndrome.

  2018cited by this paper
• Non-alcoholic fatty liver disease and colorectal cancer: A marker of risk or common causation?

  2018cited by this paper
• TET2 facilitates PPARγ agonist-mediated gene regulation and insulin sensitization in adipocytes.

  2018cited by this paper
• Follistatins in glucose regulation in healthy and obese individuals

  2018cited by this paper
• Independent relationships between cardinal features of obstructive sleep apnea and glycometabolism: a cross-sectional study.

  2018cited by this paper
• Metformin increases urinary sodium excretion by reducing phosphorylation of the sodium-chloride cotransporter.

  2018cited by this paper
• Skeletal muscle ceramides and daily fat oxidation in obesity and diabetes.

  2018cited by this paper
• FAM3 gene family: A promising therapeutical target for NAFLD and type 2 diabetes.

  2018cited by this paper
• Activation of the STING-IRF3 pathway promotes hepatocyte inflammation, apoptosis and induces metabolic disorders in nonalcoholic fatty liver disease.

  2018cited by this paper
• Impact of systemic inflammation on the relationship between insulin resistance and all-cause and cancer-related mortality.

  2018cited by this paper
• Exenatide has a pronounced effect on energy intake but not energy expenditure in non-diabetic subjects with obesity: A randomized, double-blind, placebo-controlled trial.

  2018cited by this paper
• TGF-β1 down-regulation in the mediobasal hypothalamus attenuates hypothalamic inflammation and protects against diet-induced obesity.

  2018cited by this paper
• Losartan prevents the imbalance between renal dopaminergic and renin angiotensin systems induced by fructose overload. l-Dopa/dopamine index as new potential biomarker of renal dysfunction.

  2018cited by this paper
• Theacrine protects against nonalcoholic fatty liver disease by regulating acylcarnitine metabolism.

  2018cited by this paper
• Effects of a combined dietary, exercise and behavioral intervention and sympathetic system on body weight maintenance after intended weight loss: Results of a randomized controlled trial.

  2018cited by this paper
• Nicotinic acetylcholine receptor α7 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease.

  2018cited by this paper
• Regulation of the activins-follistatins-inhibins axis by energy status: Impact on reproductive function.

  2018cited by this paper
• A whole-grain diet reduces peripheral insulin resistance and improves glucose kinetics in obese adults: A randomized-controlled trial.

  2018cited by this paper
• Differential effects of saturated fatty acids on the risk of metabolic syndrome: a matched case-control and meta-analysis study.

  2018cited by this paper
• FNDC5 attenuates adipose tissue inflammation and insulin resistance via AMPK-mediated macrophage polarization in obesity.

  2018cited by this paper
• Circulating ApoJ is closely associated with insulin resistance in human subjects.

  2018cited by this paper
• Metabolic phenotyping using kinetic measurements in young and older healthy adults.

  2018cited by this paper
• Decreased RNF41 expression leads to insulin resistance in skeletal muscle of obese women.

  2018cited by this paper
• Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.

  2018cited by this paper
• Association between plasma ceramides and inducible myocardial ischemia in patients with established or suspected coronary artery disease undergoing myocardial perfusion scintigraphy.

  2018cited by this paper
• Change in circulating microRNA profile of obese children indicates future risk of adult diabetes.

  2018cited by this paper
• Use of BMI as the marker of adiposity in a metabolic syndrome severity score: Derivation and validation in predicting long-term disease outcomes.

  2018cited by this paper
• Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes

  2017cited by this paper
• Urine clusterin/apolipoprotein J is linked to tubular damage and renal outcomes in patients with type 2 diabetes mellitus

  2017cited by this paper
• Circulating triacylglycerols but not pancreatic fat associate with insulin secretion in healthy humans.

  2017cited by this paper
• Clusterin/apolipoprotein J is independently associated with survival in patients with chronic heart failure.

  2017cited by this paper
• The effect of the GLP‐1 analogue Exenatide on functional connectivity within an NTS‐based network in women with and without obesity

  2017cited by this paper
• NAFLD and liver transplantation: Current burden and expected challenges.

  2016cited by this paper
• Short-term administration of the GLP-1 analog liraglutide decreases circulating leptin and increases GIP levels and these changes are associated with alterations in CNS responses to food cues: A randomized, placebo-controlled, crossover study.

  2016cited by this paper
• GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial

  2016cited by this paper
• Liraglutide Reduces CNS Activation in Response to Visual Food Cues Only After Short-term Treatment in Patients With Type 2 Diabetes

  2015cited by this paper
• Apolipoprotein J: A New Predictor and Therapeutic Target in Cardiovascular Disease?

  2015cited by this paper
• Brain reward‐system activation in response to anticipation and consumption of palatable food is altered by glucagon‐like peptide‐1 receptor activation in humans

  2015cited by this paper
• The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases

  2014cited by this paper

• The serum metabolome of COVID-19 patients is distinctive and predictive

  2021cites this paper
• Lipid Metabolism Profiles in Rheumatic Diseases

  2021cites this paper
• The role of metabolism in the pathogenesis of systemic sclerosis.

  2019cites this paper